Orthofix products address health needs of patients with internal and external fixators, nailing and plating systems, soft tissue management products, bone growth stimulators, bracing and pain management products
Orthofix to Present at 29th Annual Piper Jaffray Healthcare Conference Tue, 21 Nov 2017 13:30:00 +0000 Orthofix International N.V. , a diversified, global medical device company, today announced that President and Chief Executive Officer Brad Mason will present at the 29th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 29, 2017 at 10:10 a.m.
ETFs with exposure to Orthofix International NV : November 15, 2017 Wed, 15 Nov 2017 17:13:24 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Orthofix International NV Here are 5 ETFs with the largest exposure to OFIX-US. Comparing the performance and risk of Orthofix International NV with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
Orthofix to Present at Jefferies 2017 London Healthcare Conference Mon, 06 Nov 2017 13:00:00 +0000 Orthofix International N.V. , a diversified, global medical device company, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2017 London Healthcare Conference in London, on Thursday, November 16, 2017 at 10:20 a.m.
Orthofix International NV :OFIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017 Wed, 01 Nov 2017 13:41:56 +0000 Categories: Yahoo FinanceGet free summary analysis Orthofix International NV reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Orthofix International NV – NuVasive, Inc. and Stryker Corporation (NUVA-US and SYK-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 105.25 million, Net ... Read more
(Read more...)
Orthofix beats 3Q profit forecasts Mon, 30 Oct 2017 20:11:19 +0000 The Willemstad, Netherlands Antilles-based company said it had profit of 19 cents per share. Earnings, adjusted for one-time gains and costs, came to 42 cents per share. The results surpassed Wall Street ...
Orthofix International Reports Third Quarter 2017 Financial Results Mon, 30 Oct 2017 20:02:00 +0000 Orthofix International N.V. today reported its financial results for the third quarter ended September 30, 2017. Net sales were $105.2 million, diluted earnings per share from continuing operations was $0.18 and adjusted earnings per share from continuing operations was $0.42.
Orthofix Wins 2017 Spine Technology Award for STIM onTrack Mobile App Wed, 25 Oct 2017 12:00:00 +0000 Orthofix International N.V. , a diversified, global medical device company, today announced that its STIM onTrack™ mobile app has earned the 2017 Spine Technology Award in the Cervical Care category from Orthopedics This Week, the most widely read publication in the Orthopedics industry.
Fresenius Medical (FMS) Well Poised on Growth Strategy 2020 Tue, 10 Oct 2017 13:00:01 +0000 Fresenius Medical (FMS) is banking on its Growth Strategy 2020 plan for gaining market traction in the future. However, lackluster performance in the bourse is a concern.
Boston Scientific Grows on New Products, Currency Woe Ails Mon, 09 Oct 2017 18:59:06 +0000 Boston Scientific (BSX) is gaining traction on product launch and accretive acquisitions. Yet an unfavorable currency movement is a major dampener.
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 1.12 (median winner: 1.53)
Group Action: 15 (median winner: 20)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.